Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients.
Coomans MB, Taphoorn MJB, Aaronson NK, Baumert BG, van den Bent M, Bottomley A, Brandes AA, Chinot O, Coens C, Gorlia T, Herrlinger U, Keime-Guibert F, Malmström A, Martinelli F, Stupp R, Talacchi A, Weller M, Wick W, Reijneveld JC, Dirven L. Coomans MB, et al. Among authors: baumert bg. Neurooncol Pract. 2020 Jun 7;7(6):668-675. doi: 10.1093/nop/npaa033. eCollection 2020 Dec. Neurooncol Pract. 2020. PMID: 33304601 Free PMC article.
Health-related quality of life in patients with glioblastoma: a randomised controlled trial.
Taphoorn MJ, Stupp R, Coens C, Osoba D, Kortmann R, van den Bent MJ, Mason W, Mirimanoff RO, Baumert BG, Eisenhauer E, Forsyth P, Bottomley A; European Organisation for Research and Treatment of Cancer Brain Tumour Group; EORTC Radiotherapy Group; National Cancer Institute of Canada Clinical Trials Group. Taphoorn MJ, et al. Among authors: baumert bg. Lancet Oncol. 2005 Dec;6(12):937-44. doi: 10.1016/S1470-2045(05)70432-0. Lancet Oncol. 2005. PMID: 16321761 Clinical Trial.
Low-grade glioma: a challenge in therapeutic options: the role of radiotherapy.
Baumert BG, Stupp R; European Organization for Research and Treatment of Cancer (EORTC) Radiation Oncology Group; European Organization for Research and Treatment of Cancer (EORTC) Brain Tumor Group. Baumert BG, et al. Ann Oncol. 2008 Sep;19 Suppl 7:vii217-22. doi: 10.1093/annonc/mdn434. Ann Oncol. 2008. PMID: 18790954 Free article. No abstract available.
Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force.
Soffietti R, Baumert BG, Bello L, Von Deimling A, Duffau H, Frénay M, Grisold W, Grant R, Graus F, Hoang-Xuan K, Klein M, Melin B, Rees J, Siegal T, Smits A, Stupp R, Wick W. Soffietti R, et al. Among authors: baumert bg. Eur J Neurol. 2010 Sep;17(9):1124-1133. doi: 10.1111/j.1468-1331.2010.03151.x. Eur J Neurol. 2010. PMID: 20718851
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.
van den Bent MJ, Wefel JS, Schiff D, Taphoorn MJ, Jaeckle K, Junck L, Armstrong T, Choucair A, Waldman AD, Gorlia T, Chamberlain M, Baumert BG, Vogelbaum MA, Macdonald DR, Reardon DA, Wen PY, Chang SM, Jacobs AH. van den Bent MJ, et al. Among authors: baumert bg. Lancet Oncol. 2011 Jun;12(6):583-93. doi: 10.1016/S1470-2045(11)70057-2. Epub 2011 Apr 5. Lancet Oncol. 2011. PMID: 21474379 Review.
Appropriate end-points for right results in the age of antiangiogenic agents: future options for phase II trials in patients with recurrent glioblastoma.
Brandes AA, Franceschi E, Gorlia T, Wick W, Jacobs AH, Baumert BG, van den Bent M, Weller M, Stupp R; European Organisation for Research and Treatment of Cancer Brain Tumour Group. Brandes AA, et al. Among authors: baumert bg. Eur J Cancer. 2012 Apr;48(6):896-903. doi: 10.1016/j.ejca.2011.10.027. Epub 2011 Nov 24. Eur J Cancer. 2012. PMID: 22119352 Review.
145 results